Specialty Business Services
Compare Stocks
2 / 10Stock Comparison
DLHC vs CRAI
Revenue, margins, valuation, and 5-year total return — side by side.
Consulting Services
DLHC vs CRAI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Specialty Business Services | Consulting Services |
| Market Cap | $83M | $899M |
| Revenue (TTM) | $293M | $771M |
| Net Income (TTM) | $-4M | $48M |
| Gross Margin | 14.4% | 20.3% |
| Operating Margin | 2.5% | 9.8% |
| Forward P/E | 60.8x | 16.9x |
| Total Debt | $145M | $127M |
| Cash & Equiv. | $125K | $18M |
DLHC vs CRAI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| DLH Holdings Corp. (DLHC) | 100 | 77.4 | -22.6% |
| CRA International, … (CRAI) | 100 | 344.4 | +244.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: DLHC vs CRAI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
DLHC is the clearest fit if your priority is momentum.
- +41.5% vs CRAI's -20.7%
CRAI carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 9 yrs, beta 0.73, yield 1.5%
- Rev growth 9.3%, EPS growth 20.8%, 3Y rev CAGR 8.3%
- 5.5% 10Y total return vs DLHC's 24.0%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 9.3% revenue growth vs DLHC's -13.0% | |
| Value | Lower P/E (16.9x vs 60.8x) | |
| Quality / Margins | 6.2% margin vs DLHC's -1.5% | |
| Stability / Safety | Beta 0.73 vs DLHC's 0.82, lower leverage | |
| Dividends | 1.5% yield; 9-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | +41.5% vs CRAI's -20.7% | |
| Efficiency (ROA) | 7.6% ROA vs DLHC's -1.6%, ROIC 20.4% vs 4.7% |
DLHC vs CRAI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
DLHC vs CRAI — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
CRAI leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CRAI is the larger business by revenue, generating $771M annually — 2.6x DLHC's $293M. CRAI is the more profitable business, keeping 6.2% of every revenue dollar as net income compared to DLHC's -1.5%. On growth, CRAI holds the edge at +10.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $293M | $771M |
| EBITDAEarnings before interest/tax | $25M | $98M |
| Net IncomeAfter-tax profit | -$4M | $48M |
| Free Cash FlowCash after capex | $19M | -$17M |
| Gross MarginGross profit ÷ Revenue | +14.4% | +20.3% |
| Operating MarginEBIT ÷ Revenue | +2.5% | +9.8% |
| Net MarginNet income ÷ Revenue | -1.5% | +6.2% |
| FCF MarginFCF ÷ Revenue | +6.5% | -2.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | -33.6% | +10.5% |
| EPS Growth (YoY)Latest quarter vs prior year | -4.0% | -35.5% |
Valuation Metrics
DLHC leads this category, winning 4 of 5 comparable metrics.
Valuation Metrics
At 17.1x trailing earnings, CRAI trades at a 72% valuation discount to DLHC's 60.8x P/E. On an enterprise value basis, DLHC's 6.7x EV/EBITDA is more attractive than CRAI's 10.4x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $83M | $899M |
| Enterprise ValueMkt cap + debt − cash | $228M | $1.0B |
| Trailing P/EPrice ÷ TTM EPS | 60.83x | 17.09x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 16.88x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.79x |
| EV / EBITDAEnterprise value multiple | 6.71x | 10.36x |
| Price / SalesMarket cap ÷ Revenue | 0.24x | 1.20x |
| Price / BookPrice ÷ Book value/share | 0.73x | 4.37x |
| Price / FCFMarket cap ÷ FCF | 3.61x | 48.45x |
Profitability & Efficiency
CRAI leads this category, winning 8 of 9 comparable metrics.
Profitability & Efficiency
CRAI delivers a 23.6% return on equity — every $100 of shareholder capital generates $24 in annual profit, vs $-4 for DLHC. CRAI carries lower financial leverage with a 0.60x debt-to-equity ratio, signaling a more conservative balance sheet compared to DLHC's 1.28x. On the Piotroski fundamental quality scale (0–9), DLHC scores 5/9 vs CRAI's 4/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -4.0% | +23.6% |
| ROA (TTM)Return on assets | -1.6% | +7.6% |
| ROICReturn on invested capital | +4.7% | +20.4% |
| ROCEReturn on capital employed | +6.6% | +26.9% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 4 |
| Debt / EquityFinancial leverage | 1.28x | 0.60x |
| Net DebtTotal debt minus cash | $145M | $109M |
| Cash & Equiv.Liquid assets | $125,000 | $18M |
| Total DebtShort + long-term debt | $145M | $127M |
| Interest CoverageEBIT ÷ Interest expense | 0.46x | 14.51x |
Total Returns (Dividends Reinvested)
CRAI leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CRAI five years ago would be worth $17,152 today (with dividends reinvested), compared to $5,601 for DLHC. Over the past 12 months, DLHC leads with a +41.5% total return vs CRAI's -20.7%. The 3-year compound annual growth rate (CAGR) favors CRAI at 15.5% vs DLHC's -17.6% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +2.7% | -30.3% |
| 1-Year ReturnPast 12 months | +41.5% | -20.7% |
| 3-Year ReturnCumulative with dividends | -44.1% | +54.1% |
| 5-Year ReturnCumulative with dividends | -44.0% | +71.5% |
| 10-Year ReturnCumulative with dividends | +24.0% | +550.5% |
| CAGR (3Y)Annualised 3-year return | -17.6% | +15.5% |
Risk & Volatility
Evenly matched — DLHC and CRAI each lead in 1 of 2 comparable metrics.
Risk & Volatility
CRAI is the less volatile stock with a 0.73 beta — it tends to amplify market swings less than DLHC's 0.82 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. DLHC currently trades 70.7% from its 52-week high vs CRAI's 61.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.82x | 0.73x |
| 52-Week HighHighest price in past year | $8.10 | $227.29 |
| 52-Week LowLowest price in past year | $3.95 | $135.95 |
| % of 52W HighCurrent price vs 52-week peak | +70.7% | +61.2% |
| RSI (14)Momentum oscillator 0–100 | 45.4 | 41.1 |
| Avg Volume (50D)Average daily shares traded | 8K | 187K |
Analyst Outlook
CRAI leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
CRAI is the only dividend payer here at 1.48% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy |
| Price TargetConsensus 12-month target | — | $194.00 |
| # AnalystsCovering analysts | — | 1 |
| Dividend YieldAnnual dividend ÷ price | — | +1.5% |
| Dividend StreakConsecutive years of raises | 1 | 9 |
| Dividend / ShareAnnual DPS | — | $2.06 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +5.2% |
CRAI leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). DLHC leads in 1 (Valuation Metrics). 1 tied.
DLHC vs CRAI: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is DLHC or CRAI a better buy right now?
For growth investors, CRA International, Inc.
(CRAI) is the stronger pick with 9. 3% revenue growth year-over-year, versus -13. 0% for DLH Holdings Corp. (DLHC). CRA International, Inc. (CRAI) offers the better valuation at 17. 1x trailing P/E (16. 9x forward), making it the more compelling value choice. Analysts rate CRA International, Inc. (CRAI) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — DLHC or CRAI?
On trailing P/E, CRA International, Inc.
(CRAI) is the cheapest at 17. 1x versus DLH Holdings Corp. at 60. 8x.
03Which is the better long-term investment — DLHC or CRAI?
Over the past 5 years, CRA International, Inc.
(CRAI) delivered a total return of +71. 5%, compared to -44. 0% for DLH Holdings Corp. (DLHC). Over 10 years, the gap is even starker: CRAI returned +550. 5% versus DLHC's +24. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — DLHC or CRAI?
By beta (market sensitivity over 5 years), CRA International, Inc.
(CRAI) is the lower-risk stock at 0. 73β versus DLH Holdings Corp. 's 0. 82β — meaning DLHC is approximately 13% more volatile than CRAI relative to the S&P 500. On balance sheet safety, CRA International, Inc. (CRAI) carries a lower debt/equity ratio of 60% versus 128% for DLH Holdings Corp. — giving it more financial flexibility in a downturn.
05Which is growing faster — DLHC or CRAI?
By revenue growth (latest reported year), CRA International, Inc.
(CRAI) is pulling ahead at 9. 3% versus -13. 0% for DLH Holdings Corp. (DLHC). On earnings-per-share growth, the picture is similar: CRA International, Inc. grew EPS 20. 8% year-over-year, compared to -81. 5% for DLH Holdings Corp.. Over a 3-year CAGR, CRAI leads at 8. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — DLHC or CRAI?
CRA International, Inc.
(CRAI) is the more profitable company, earning 7. 3% net margin versus 0. 4% for DLH Holdings Corp. — meaning it keeps 7. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CRAI leads at 11. 1% versus 4. 9% for DLHC. At the gross margin level — before operating expenses — CRAI leads at 29. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Which pays a better dividend — DLHC or CRAI?
In this comparison, CRAI (1.
5% yield) pays a dividend. DLHC does not pay a meaningful dividend and should not be held primarily for income.
08Is DLHC or CRAI better for a retirement portfolio?
For long-horizon retirement investors, CRA International, Inc.
(CRAI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 73), 1. 5% yield, +550. 5% 10Y return). Both have compounded well over 10 years (CRAI: +550. 5%, DLHC: +24. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between DLHC and CRAI?
Both stocks operate in the null sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: DLHC is a small-cap quality compounder stock; CRAI is a small-cap deep-value stock. CRAI pays a dividend while DLHC does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.